Agreement signedAgreed 10 Jan 2025
Salarius Pharmaceuticals, Inc. /
Decoy Therapeutics Inc.
Salarius Pharmaceuticals updates merger terms with Decoy Therapeutics
01 / BuyerSalarius Pharmaceuticals, Inc.
02 / TargetDecoy Therapeutics Inc.
Source for the buyer and target: Salarius Pharmaceuticals, Inc.
For the buyer and target.
“As previously disclosed, Salarius Pharmaceuticals, Inc. (the “Company”) entered into an Agreement and Plan of Merger dated January 10, 2025, as previously amended by the First Amendment on March 28, 2025, by the Second Amendment on June 10, 2025, by the Third Amendment on June 18, 2025, and by the Fourth Amendment on July 29, 2025 (as amended, collectively, the “Merger Agreement”) with Decoy Therapeutics MergerSub I, Inc., Decoy Therapeutics MergerSub II, LLC, and Decoy Therapeutics Inc. (“Decoy”).”
Published 18 Sep 2025
Open the sourceWhat happened
Salarius Pharmaceuticals, Inc. and Decoy Therapeutics Inc. amended their merger agreement. The filing says the amendment modifies conversion terms for preferred stock. [01]
The source
Everything on this page comes from the source below, quoted word for word.
01
Source · Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals updates merger terms with Decoy Therapeutics
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly